MDGL logo

Madrigal Pharmaceuticals, Inc. (MDGL) Net Income

Annual Net Income:

-$465.89M-$92.26M(-24.69%)
December 31, 2024

Summary

  • As of today, MDGL annual net profit is -$465.89 million, with the most recent change of -$92.26 million (-24.69%) on December 31, 2024.
  • During the last 3 years, MDGL annual net income has fallen by -$224.05 million (-92.64%).
  • MDGL annual net income is now -689.08% below its all-time high of $79.09 million, reached on December 31, 2009.

Performance

MDGL Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

Quarterly Net Income:

-$42.28M+$30.96M(+42.27%)
June 30, 2025

Summary

  • As of today, MDGL quarterly net profit is -$42.28 million, with the most recent change of +$30.96 million (+42.27%) on June 30, 2025.
  • Over the past year, MDGL quarterly net income has increased by +$109.69 million (+72.18%).
  • MDGL quarterly net income is now -135.80% below its all-time high of $118.12 million, reached on September 30, 2009.

Performance

MDGL Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

TTM Net Income:

-$281.90M+$109.69M(+28.01%)
June 30, 2025

Summary

  • As of today, MDGL TTM net profit is -$281.90 million, with the most recent change of +$109.69 million (+28.01%) on June 30, 2025.
  • Over the past year, MDGL TTM net income has increased by +$228.55 million (+44.77%).
  • MDGL TTM net income is now -402.21% below its all-time high of $93.28 million, reached on March 31, 2010.

Performance

MDGL TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherMDGLincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

MDGL Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-24.7%+72.2%+44.8%
3Y3 Years-92.6%+40.2%-10.2%
5Y5 Years-455.0%+13.8%-65.0%

MDGL Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-92.6%at lowat high+72.2%-2.9%+45.6%
5Y5-Year-455.0%at lowat high+72.2%-65.0%+45.6%
All-TimeAll-Time-689.1%at low-135.8%+72.2%-402.2%+45.6%

MDGL Net Income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$42.28M(+42.3%)
-$281.90M(+28.0%)
Mar 2025
-
-$73.24M(-23.3%)
-$391.59M(+15.9%)
Dec 2024
-$465.89M(-24.7%)
-$59.42M(+44.5%)
-$465.89M(+10.2%)
Sep 2024
-
-$106.96M(+29.6%)
-$518.67M(-1.6%)
Jun 2024
-
-$151.97M(-3.0%)
-$510.45M(-14.9%)
Mar 2024
-
-$147.54M(-31.5%)
-$444.27M(-18.9%)
Dec 2023
-$373.63M(-26.5%)
-$112.19M(-13.6%)
-$373.63M(-7.6%)
Sep 2023
-
-$98.74M(-15.1%)
-$347.34M(-5.3%)
Jun 2023
-
-$85.80M(-11.6%)
-$329.80M(-4.8%)
Mar 2023
-
-$76.90M(+10.5%)
-$314.73M(-6.6%)
Dec 2022
-$295.35M(-22.1%)
-$85.91M(-5.8%)
-$295.35M(-7.8%)
Sep 2022
-
-$81.20M(-14.8%)
-$273.99M(-7.1%)
Jun 2022
-
-$70.73M(-23.0%)
-$255.90M(-3.7%)
Mar 2022
-
-$57.52M(+10.9%)
-$246.82M(-2.1%)
Dec 2021
-$241.85M(-19.6%)
-$64.55M(-2.3%)
-$241.85M(-2.3%)
Sep 2021
-
-$63.10M(-2.4%)
-$236.42M(-2.2%)
Jun 2021
-
-$61.65M(-17.3%)
-$231.28M(-5.8%)
Mar 2021
-
-$52.55M(+11.1%)
-$218.66M(-8.1%)
Dec 2020
-$202.24M(-140.9%)
-$59.12M(-2.0%)
-$202.24M(-18.4%)
Sep 2020
-
-$57.96M(-18.2%)
-$170.86M(-27.2%)
Jun 2020
-
-$49.02M(-35.7%)
-$134.33M(-27.9%)
Mar 2020
-
-$36.13M(-30.3%)
-$105.00M(-25.1%)
Dec 2019
-$83.95M(-155.9%)
-$27.74M(-29.5%)
-$83.95M(-24.0%)
Sep 2019
-
-$21.43M(-8.8%)
-$67.68M(-23.6%)
Jun 2019
-
-$19.70M(-30.6%)
-$54.77M(-31.9%)
Mar 2019
-
-$15.08M(-31.4%)
-$41.53M(-26.6%)
Dec 2018
-$32.81M(-5.3%)
-$11.47M(-34.8%)
-$32.81M(-10.2%)
Sep 2018
-
-$8.51M(-31.8%)
-$29.78M(-0.5%)
Jun 2018
-
-$6.46M(-1.5%)
-$29.63M(+6.0%)
Mar 2018
-
-$6.36M(+24.6%)
-$31.52M(-1.2%)
Dec 2017
-$31.15M(-18.1%)
-$8.45M(-1.0%)
-$31.15M(-2.3%)
Sep 2017
-
-$8.36M(-0.2%)
-$30.46M(+15.7%)
Jun 2017
-
-$8.35M(-39.1%)
-$36.14M(-17.8%)
Mar 2017
-
-$6.00M(+22.6%)
-$30.67M(-16.2%)
Dec 2016
-$26.39M(-285.5%)
-$7.75M(+44.8%)
-$26.39M(-28.6%)
Sep 2016
-
-$14.05M(-388.3%)
-$20.52M(-148.1%)
Jun 2016
-
-$2.88M(-68.0%)
-$8.27M(+67.2%)
Mar 2016
-
-$1.71M(+9.0%)
-$25.20M(+43.0%)
Dec 2015
-$6.84M(+92.1%)
-$1.88M(-4.6%)
-$44.19M(+29.5%)
Sep 2015
-
-$1.80M(+90.9%)
-$62.66M(+22.5%)
Jun 2015
-
-$19.80M(+4.4%)
-$80.83M(+3.0%)
Mar 2015
-
-$20.71M(-1.7%)
-$83.31M(+3.3%)
DateAnnualQuarterlyTTM
Dec 2014
-$86.16M(+4.5%)
-$20.35M(-1.9%)
-$86.16M(+4.2%)
Sep 2014
-
-$19.97M(+10.4%)
-$89.97M(+2.8%)
Jun 2014
-
-$22.29M(+5.4%)
-$92.52M(+0.5%)
Mar 2014
-
-$23.56M(+2.5%)
-$93.02M(-3.1%)
Dec 2013
-$90.19M(-43.6%)
-$24.16M(-7.3%)
-$90.19M(-7.2%)
Sep 2013
-
-$22.52M(+1.2%)
-$84.15M(-9.8%)
Jun 2013
-
-$22.79M(-9.9%)
-$76.63M(-11.9%)
Mar 2013
-
-$20.73M(-14.4%)
-$68.47M(-9.0%)
Dec 2012
-$62.79M(-32.5%)
-$18.12M(-20.9%)
-$62.79M(-13.3%)
Sep 2012
-
-$15.00M(-2.6%)
-$55.41M(-4.3%)
Jun 2012
-
-$14.62M(+2.9%)
-$53.15M(-4.2%)
Mar 2012
-
-$15.05M(-40.1%)
-$51.03M(-7.7%)
Dec 2011
-$47.38M(-26.5%)
-$10.74M(+15.6%)
-$47.38M(-4.2%)
Sep 2011
-
-$12.73M(-1.9%)
-$45.46M(-5.8%)
Jun 2011
-
-$12.50M(-9.7%)
-$42.99M(-8.7%)
Mar 2011
-
-$11.40M(-29.2%)
-$39.56M(-5.6%)
Dec 2010
-$37.47M(-147.4%)
-$8.82M(+14.0%)
-$37.47M(-5.0%)
Sep 2010
-
-$10.26M(-13.1%)
-$35.68M(-138.5%)
Jun 2010
-
-$9.07M(+2.5%)
$92.70M(-0.6%)
Mar 2010
-
-$9.31M(-32.3%)
$93.28M(+17.9%)
Dec 2009
$79.09M(+185.4%)
-$7.04M(-106.0%)
$79.09M(+31.4%)
Sep 2009
-
$118.12M(+1490.5%)
$60.17M(+171.4%)
Jun 2009
-
-$8.49M(+63.8%)
-$84.27M(+14.4%)
Mar 2009
-
-$23.50M(+9.5%)
-$98.47M(-6.3%)
Dec 2008
-$92.62M(-45.9%)
-$25.95M(+1.4%)
-$92.62M(-12.7%)
Sep 2008
-
-$26.32M(-16.0%)
-$82.19M(-16.2%)
Jun 2008
-
-$22.69M(-28.6%)
-$70.74M(-9.2%)
Mar 2008
-
-$17.65M(-13.7%)
-$64.79M(-2.0%)
Dec 2007
-$63.49M(-10.9%)
-$15.52M(-4.4%)
-$63.49M(-5.0%)
Sep 2007
-
-$14.88M(+11.1%)
-$60.46M(-1.6%)
Jun 2007
-
-$16.74M(-2.4%)
-$59.51M(-3.6%)
Mar 2007
-
-$16.36M(-31.0%)
-$57.41M(-0.3%)
Dec 2006
-$57.27M(+16.8%)
-$12.49M(+10.3%)
-$57.27M(-27.9%)
Sep 2006
-
-$13.93M(+4.9%)
-$44.78M(-45.1%)
Jun 2006
-
-$14.65M(+9.7%)
-$30.86M(-90.3%)
Mar 2006
-
-$16.21M(+12.4%)
-$16.21M(+12.4%)
Dec 2005
-$68.86M(-49.9%)
-
-
Mar 2005
-
-$18.50M(-111.2%)
-$18.50M(-111.2%)
Dec 2004
-$45.93M(-64.8%)
-
-
Mar 2004
-
-$8.76M
-$8.76M
Dec 2003
-$27.88M(+22.9%)
-
-
Dec 2002
-$36.15M(-9389.2%)
-
-
Dec 2001
-$381.00K
-
-

FAQ

  • What is Madrigal Pharmaceuticals, Inc. annual net profit?
  • What is the all-time high annual net income for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. quarterly net profit?
  • What is the all-time high quarterly net income for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Madrigal Pharmaceuticals, Inc. TTM net profit?
  • What is the all-time high TTM net income for Madrigal Pharmaceuticals, Inc.?
  • What is Madrigal Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Madrigal Pharmaceuticals, Inc. annual net profit?

The current annual net income of MDGL is -$465.89M

What is the all-time high annual net income for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high annual net profit is $79.09M

What is Madrigal Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, MDGL annual net profit has changed by -$92.26M (-24.69%)

What is Madrigal Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of MDGL is -$42.28M

What is the all-time high quarterly net income for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high quarterly net profit is $118.12M

What is Madrigal Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, MDGL quarterly net profit has changed by +$109.69M (+72.18%)

What is Madrigal Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of MDGL is -$281.90M

What is the all-time high TTM net income for Madrigal Pharmaceuticals, Inc.?

Madrigal Pharmaceuticals, Inc. all-time high TTM net profit is $93.28M

What is Madrigal Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, MDGL TTM net profit has changed by +$228.55M (+44.77%)
On this page